No direct mention of IXHL/Clarion but this article was very informative regarding peers, process and subsidies for treatment already availablehttps://cosmosmagazine.com/health/its-legal-but/
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%